11
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      High-fat diet-induced upregulation of exosomal phosphatidylcholine contributes to insulin resistance

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          High-fat diet (HFD) decreases insulin sensitivity. How high-fat diet causes insulin resistance is largely unknown. Here, we show that lean mice become insulin resistant after being administered exosomes isolated from the feces of obese mice fed a HFD or from patients with type II diabetes. HFD altered the lipid composition of exosomes from predominantly phosphatidylethanolamine (PE) in exosomes from lean animals (L-Exo) to phosphatidylcholine (PC) in exosomes from obese animals (H-Exo). Mechanistically, we show that intestinal H-Exo is taken up by macrophages and hepatocytes, leading to inhibition of the insulin signaling pathway. Moreover, exosome-derived PC binds to and activates AhR, leading to inhibition of the expression of genes essential for activation of the insulin signaling pathway, including IRS-2, and its downstream genes PI3K and Akt. Together, our results reveal HFD-induced exosomes as potential contributors to the development of insulin resistance. Intestinal exosomes thus have potential as broad therapeutic targets.

          Abstract

          High-fat diet plays a role in development of insulin resistance. Here, the authors report a mechanism that underlies the development of diet induced insulin resistance through the activation of an aryl hydrocarbon receptor mediated signalling pathway in the liver by faecal exosomes derived from intestinal cells.

          Related collections

          Most cited references75

          • Record: found
          • Abstract: found
          • Article: not found

          Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes.

          Extracellular vesicles (EVs) have become the focus of rising interest because of their numerous functions in physiology and pathology. Cells release heterogeneous vesicles of different sizes and intracellular origins, including small EVs formed inside endosomal compartments (i.e., exosomes) and EVs of various sizes budding from the plasma membrane. Specific markers for the analysis and isolation of different EV populations are missing, imposing important limitations to understanding EV functions. Here, EVs from human dendritic cells were first separated by their sedimentation speed, and then either by their behavior upon upward floatation into iodixanol gradients or by immuno-isolation. Extensive quantitative proteomic analysis allowing comparison of the isolated populations showed that several classically used exosome markers, like major histocompatibility complex, flotillin, and heat-shock 70-kDa proteins, are similarly present in all EVs. We identified proteins specifically enriched in small EVs, and define a set of five protein categories displaying different relative abundance in distinct EV populations. We demonstrate the presence of exosomal and nonexosomal subpopulations within small EVs, and propose their differential separation by immuno-isolation using either CD63, CD81, or CD9. Our work thus provides guidelines to define subtypes of EVs for future functional studies.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            AKT/PKB Signaling: Navigating the Network

            The Ser/Thr kinase AKT, also known as protein kinase B (PKB), was discovered 25 years ago and has been the focus of tens of thousands of studies in diverse fields of biology and medicine. There have been many advances in our knowledge of the upstream regulatory inputs into AKT, key multifunctional downstream signaling nodes (GSK3, FoxO, mTORC1), which greatly expand the functional repertoire of Akt, and the complex circuitry of this dynamically branching and looping signaling network that is ubiquitous to nearly every cell in our body. Mouse and human genetic studies have also revealed physiological roles for the AKT network in nearly every organ system. Our comprehension of AKT regulation and functions is particularly important given the consequences of AKT dysfunction in diverse pathological settings, including developmental and overgrowth syndromes, cancer, cardiovascular disease, insulin resistance and type-2 diabetes, inflammatory and autoimmune disorders, and neurological disorders. There has also been much progress in developing AKT-selective small molecule inhibitors. Improved understanding of the molecular wiring of the AKT signaling network continues to make an impact that cuts across most disciplines of the biomedical sciences.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Gut microbial metabolites in obesity, NAFLD and T2DM

              Evidence is accumulating that the gut microbiome is involved in the aetiology of obesity and obesity-related complications such as nonalcoholic fatty liver disease (NAFLD), insulin resistance and type 2 diabetes mellitus (T2DM). The gut microbiota is able to ferment indigestible carbohydrates (for example, dietary fibre), thereby yielding important metabolites such as short-chain fatty acids and succinate. Numerous animal studies and a handful of human studies suggest a beneficial role of these metabolites in the prevention and treatment of obesity and its comorbidities. Interestingly, the more distal colonic microbiota primarily ferments peptides and proteins, as availability of fermentable fibre, the major energy source for the microbiota, is limited here. This proteolytic fermentation yields mainly harmful products such as ammonia, phenols and branched-chain fatty acids, which might be detrimental for host gut and metabolic health. Therefore, a switch from proteolytic to saccharolytic fermentation could be of major interest for the prevention and/or treatment of metabolic diseases. This Review focuses on the role of products derived from microbial carbohydrate and protein fermentation in relation to obesity and obesity-associated insulin resistance, T2DM and NAFLD, and discusses the mechanisms involved.
                Bookmark

                Author and article information

                Contributors
                yun.teng@louisville.edu
                h0zhan17@louisville.edu
                Journal
                Nat Commun
                Nat Commun
                Nature Communications
                Nature Publishing Group UK (London )
                2041-1723
                11 January 2021
                11 January 2021
                2021
                : 12
                : 213
                Affiliations
                [1 ]GRID grid.266623.5, ISNI 0000 0001 2113 1622, James Graham Brown Cancer Center, Department of Microbiology & Immunology, , University of Louisville, ; Louisville, KY 40202 USA
                [2 ]GRID grid.266623.5, ISNI 0000 0001 2113 1622, Department of Medicine, , University of Louisville, ; Louisville, KY 40202 USA
                [3 ]GRID grid.266623.5, ISNI 0000 0001 2113 1622, Department of Pharmacology and Toxicology, , University of Louisville, ; Louisville, KY 40202 USA
                [4 ]GRID grid.266623.5, ISNI 0000 0001 2113 1622, Department of Computer Engineering and Computer Science, , University of Louisville, ; Louisville, KY 40202 USA
                [5 ]GRID grid.266623.5, ISNI 0000 0001 2113 1622, KBRIN Bioinformatics Core, , University of Louisville, ; Louisville, KY 40202 USA
                [6 ]GRID grid.266623.5, ISNI 0000 0001 2113 1622, Kidney Disease Program and Clinical Proteomics Center, , University of Louisville, ; Louisville, KY USA
                [7 ]GRID grid.266623.5, ISNI 0000 0001 2113 1622, Department of Reproductive Endocrinology and Infertility, , University of Louisville, ; Louisville, KY40202 USA
                [8 ]GRID grid.25879.31, ISNI 0000 0004 1936 8972, Department of Dermatology, , University of Pennsylvania, ; Philadelphia, 19104 USA
                [9 ]GRID grid.48336.3a, ISNI 0000 0004 1936 8075, Peeples Cancer Institute, ; 215 Memorial Drive, Dalton, GA 30720 USA
                [10 ]GRID grid.267309.9, ISNI 0000 0001 0629 5880, Barshop Institute for Longevity and Aging Studies, , University of Texas Health Science Center at San Antonio, ; San Antonio, TX 78229 USA
                [11 ]GRID grid.413902.d, ISNI 0000 0004 0419 5810, Robley Rex Veterans Affairs Medical Center, ; Louisville, KY 40206 USA
                Author information
                http://orcid.org/0000-0001-5242-1323
                http://orcid.org/0000-0002-4610-6893
                http://orcid.org/0000-0002-8615-2413
                http://orcid.org/0000-0001-9665-9202
                Article
                20500
                10.1038/s41467-020-20500-w
                7801461
                33431899
                3fe73e90-5b74-47d0-b76d-bcd2d89bc893
                © The Author(s) 2021

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 26 March 2020
                : 30 November 2020
                Funding
                Funded by: FundRef https://doi.org/10.13039/100008460, U.S. Department of Health & Human Services | NIH | National Center for Complementary and Integrative Health (NCCIH);
                Award ID: R01AT008617
                Award Recipient :
                Funded by: FundRef https://doi.org/10.13039/100000057, U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS);
                Award ID: P50 AA024337
                Award ID: P20GM125504
                Award ID: P20GM103436
                Award ID: P20GM103436
                Award Recipient :
                Funded by: U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS)
                Funded by: U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS)
                Funded by: U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS)
                Funded by: Huang-Ge Zhang is supported by a Research Career Scientist (RCS) Award
                Categories
                Article
                Custom metadata
                © The Author(s) 2021

                Uncategorized
                metabolic syndrome,hepatology,molecular medicine
                Uncategorized
                metabolic syndrome, hepatology, molecular medicine

                Comments

                Comment on this article